Abstract: |
Multidrug resistance (MDR) is a major cause of cancer progression. Tumor cells may acquire an MDR phenotype in response to many extracellular stimuli. MDR is commonly mediated by P-glycoprotein (Pgp), a transmembrane pump capable of transporting diverse compounds out of the cell. The increased amount of Pgp is associated with elevated level of mRNA of the MDR1 gene that encodes Pgp in humans. Intracellular signals triggered by xenobiotics (including anticancer drugs) converge to MDR1 overexpression, thereby leading to establishment of Pgp-mediated MDR in tumor cells. Signal transduction pathways and the MDR1 gene transcription are considered as targets for therapeutic intervention to block the emergence of MDR during treatment. |